Enlaza Therapeutics Finds $100M socaltech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socaltech.com Daily Mail and Mail on Sunday newspapers.
San Diego- and Boston-based Rapport Therapeutics has raised $150M in a Series B funding round, the company said this morning. According to the company, the funding was led by Cormorant Asset Management,
socaltech.com
San Diego-based
Pipeline Therapeutics, a biopharmaceuticals firm focused on small molecules for neuroregeneration, said on Thursday that it has raised $80M in its Series C funding. The funding included Perceptive Advisors, Franklin Templeton, Casdin Capital, Samsara BioCapital, Suvretta Capital, Red Tree Venture Capital, plus Versant Ventures, Sectoral Asset Management, Cleva Pharma (a Brace Pharma affiliate), Hadean Ventures, RBV Capital and Helicase Venture, as well as several other undisclosed investors. The lead was a healthcare-focused new investor , according to the company. The company said it will use the new funding to advance development candidates for a number of its programs. Pipeline Therapeutics is led by President and CEO Carmine Stengone.